Clinical Trial Update: Ovarian Cancer Risk Estimation in Patients With Pelvic Mass

View source ↗

Summary

A completed clinical trial update by Fujirebio Diagnostics evaluating risk estimation for ovarian cancer in patients with a pelvic mass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fujirebio Diagnostics, Inc. | Conditions: Adnexal Mass, Ovarian Cancer | Status: COMPLETED